Healthcare
Live Price
Offline$0.0011
-8.33% today
1Y Change
+50.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SOHM, Inc. (SHMN) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 50.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +24.2%, EPS growth of +166.7%, a dividend yield of 0.0%. What stands out right now is revenue +24.2%, EPS +166.7%, free cash flow 0.0% with operating margin -42.8% and ROIC -7.8%. Valuation is more restrained than many high-expectation growth names at price/sales 1.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SHMN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SHMN
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SHMN Max Drawdown
-63.16%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SHMN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$235.1K
-27.6% YoY
FY Net Income
$33.1K
-62.5% YoY
Free Cash Flow
$8.8K
-92.1% YoY
Revenue Growth
+24.2%
EPS Growth
+166.7%
Gross Margin
74.5%
Net Margin
-43.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 949K | 403K | 347K | 325K | 235K |
| Gross Profit | 673K | 257K | 185K | 174K | 90K |
| Operating Income | -605K | -295K | 94K | 89K | 34K |
| EBITDA | -605K | -127K | 94K | 326K | 34K |
| Net Income | -608K | -297K | 93K | 88K | 33K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 98K | 96K | 7K | 7K | 5K |
| Total Assets | 5M | 2M | 297K | 164K | 151K |
| Total Liabilities | 5M | 2M | 1M | 1M | 1M |
| Shareholder Equity | -94K | -371K | -999K | -1M | -1M |
| Total Debt | 4M | 2M | 1M | 1M | 1M |
| Net Debt | 4M | 2M | 1M | 1M | 1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
9K
-92.1% YoY
Capital Expenditures
0
Free Cash Flow
9K
-92.1% YoY
Key ratios
Gross Margin
74.5%
Operating Margin
-42.8%
Net Margin
-43.0%
ROE
-46.8%
Debt / Equity
0.68x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.